600721 Stock Overview
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.05 |
| 52 Week High | CN¥11.21 |
| 52 Week Low | CN¥4.31 |
| Beta | 0.13 |
| 1 Month Change | -4.42% |
| 3 Month Change | 4.49% |
| 1 Year Change | -5.47% |
| 3 Year Change | 54.34% |
| 5 Year Change | 15.02% |
| Change since IPO | -4.10% |
Recent News & Updates
Shareholder Returns
| 600721 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 13.9% | 5.6% | 3.1% |
| 1Y | -5.5% | -11.0% | -13.1% |
Return vs Industry: 600721 exceeded the CN Pharmaceuticals industry which returned -11% over the past year.
Return vs Market: 600721 exceeded the CN Market which returned -13.2% over the past year.
Price Volatility
| 600721 volatility | |
|---|---|
| 600721 Average Weekly Movement | 9.1% |
| Pharmaceuticals Industry Average Movement | 7.5% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 600721 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600721's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | 731 | Hui Huang | www.xjbhc.net |
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021.
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Fundamentals Summary
| 600721 fundamental statistics | |
|---|---|
| Market cap | CN¥2.31b |
| Earnings (TTM) | CN¥26.95m |
| Revenue (TTM) | CN¥384.44m |
85.7x
P/E Ratio6.0x
P/S RatioIs 600721 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600721 income statement (TTM) | |
|---|---|
| Revenue | CN¥384.44m |
| Cost of Revenue | CN¥192.93m |
| Gross Profit | CN¥191.51m |
| Other Expenses | CN¥164.56m |
| Earnings | CN¥26.95m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.071 |
| Gross Margin | 49.82% |
| Net Profit Margin | 7.01% |
| Debt/Equity Ratio | 0.02% |
How did 600721 perform over the long term?
See historical performance and comparison